Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial

Paul G. Richardson(Harvard University), Robert J. Soiffer(Dana-Farber Cancer Institute), Marcie Riches(Medical College of Wisconsin), Leslie Lehmann(Harvard University), Joseph M. Massaro(Boston University), Joel A. Brochstein(Cohen Children's Medical Center), Alfred P. Gillio(University Medical Center), Ralph B. D’Agostino(Wake Forest University), Eneida R. Nemecek(Oregon Health & Science University), Sally Arai(Stanford Medicine), Richard E. Champlin(The University of Texas MD Anderson Cancer Center), Joseph H. Antin(Dana-Farber Cancer Institute), Eva C. Guinan(Dana-Farber Cancer Institute), Shin Mineishi(University of Alabama at Birmingham), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Tulio E. Rodriguez(Loyola University Medical Center), Massimo Iacobelli(Figli Adottivi e Genitori Naturali), Gideon Steinbach(University of Washington), Angela R. Smith(University of Minnesota Children's Hospital), Stephan A. Grupp(Children's Hospital of Philadelphia), Nancy A. Kernan(Memorial Sloan Kettering Cancer Center), Paul Martin(Duke Medical Center), Maja Miloslavsky(Janssen (United States)), Bijan Nejadnik(Janssen (United States)), Alison L. Hannah(CytomX Therapeutics (United States)), John Doyle(Analysis Group (United States)), Reggie Duerst(Lurie Children's Hospital), Robin Hume(Jazz Pharmaceuticals (United States)), Rajinder Bajwa(Nationwide Children's Hospital), Amrita Krishnan(City of Hope), Amanda Termuhlen

Blood

December 3, 2015

Cited by 1

|Circulation|1998|9.6k

|Circulation|2008|7.4k

|New England Journal of Medicine|2018|5.7k

|Biology of Blood and Marrow Transplantation|2014|5.4k

|Circulation|1998|4.6k

Related Papers